CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it has received a Medical Device License from Health Canada for the ZOLL R Series™, which ZOLL believes is the first and only “Code-Ready” defibrillator that can help improve in-hospital resuscitation efforts. This license provides the necessary approval for the marketing and sale of the device in Canada.
